ARK stepped in while the stock was falling, across ARKG and ARKK. The rest of the day's trades, plus ARK's scorecard against the S&P 500.

Generated from ARK's own holdings data.
On 10 Sep 2026, ARK Invest bought an estimated $6.8M of Beam Therapeutics Inc (BEAM) across ARKG and ARKK. The buying landed after a 13% weekly slide in the share price.
There was almost no inflow or outflow to explain it: the 3% change was deliberate.
Over the last 30 days ARK has been a net buyer of Beam Therapeutics Inc — $13.9M across 4 trades.
ARK made 5 real moves that day, once money flowing in and out of the funds is stripped out:
| Stock | Funds | Est. value |
|---|---|---|
| META Meta Platforms Inc | ARKK and ARKW | +$28.2M |
| GOOGL Alphabet Inc | ARKK and ARKW | −$27.9M |
| BEAM Beam Therapeutics IncBought after a 13% drop this week | ARKG and ARKK | +$6.8M |
| CRSP CRISPR Therapeutics AG | ARKG and ARKK | +$2.5M |
| NTLA Intellia Therapeutics Inc | ARKG and ARKK | +$2.2M |
Over the last 30 days ARK's biggest net buys have been Cerebras Systems Inc ($85.6M), Rocket Lab ($83.2M), Nvidia Corp ($75.8M). Meanwhile the funds have been trimming Advanced Micro Devices ($143.8M), Palantir Technologies Inc ($77.3M), Shopify Inc ($67.9M).
This year ARKK is ahead of the market — +14.7% against +12.6% for the S&P 500.
ARKK has beaten the index by 7 points over the past month (+5.9% vs -0.7%), led by Circle Internet Group Inc (+39%, 4% of the fund), Tesla Inc (+11%, 9% of the fund), Robinhood Markets Inc (+22%, 4% of the fund).
That five-year gap — 111 points — mostly comes down to timing. Five years ago ARKK was trading close to its all-time high of Feb 2021. It then fell 81% to its low in Dec 2022, and it is still 43% below that peak today. Any comparison that starts near the top of that boom looks brutal.
| To date | 1 month | YTD | 1 year | 5 years |
|---|---|---|---|---|
| ARKK | +5.9% | +14.7% | +6.1% | -26.2% |
| S&P 500 (SPY) | -0.7% | +12.6% | +16.6% | +84.5% |
| Nasdaq-100 (QQQ) | +0.7% | +17.7% | +21.8% | +98.9% |
ETFpeek is an independent research tool and is not affiliated with ARK Invest or Cathie Wood. Figures are estimates from public fund data, shown for information only — not financial advice. Past performance does not indicate future results.